SummaryRecent epidemiological studies have demonstrated that nearly half of all patients with heart failure (HF) have preserved left ventricular ejection fraction (HFPEF). Compared to those with reduced EF, patients with HFPEF are older, more likely to be women, less likely to have coronary artery disease, and more likely to have hypertension and atrial fibrillation. Patients with HFPEF receive different pharmacological as well as nonpharmacological treatments from those with reduced EF. Morbidity and mortality in patients with HFPEF are largely similar to those with reduced EF. Although much information has recently been obtained about the clinical characteristics, medications, and outcomes of HFPEF by large-scale clinical and epidemiologi...
Aims: The objectives of the present study were to describe epidemiology and outcomes in ambulatory h...
Over the past 20 years, there has been a surge of clinical investigations and useful trials on heart...
Significant progress in our understanding of risk factors and interventions in heart failure, a lead...
Heart failure with preserved ejection fraction (HFpEF) has recently emerged as a major cause of card...
Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the cases of...
In the current era of cardiovascular disease, the diagnosis of heart failure with preserved ejection...
Aims: A substantial proportion of patients with heart failure have preserved left ventricular ejecti...
International audienceHeart failure with preserved ejection fraction (HFPEF) is increasingly recogni...
International audienceIt is estimated that half of all patients with heart failure (HF) have HF with...
Aims A substantial proportion of patients with heart failure have preserved left ventricular ejectio...
International audienceIt is estimated that half of all patients with heart failure (HF) have HF with...
BACKGROUND: We assessed the prevalence of preserved left ventricular ejection fraction in patients w...
International audienceIt is estimated that half of all patients with heart failure (HF) have HF with...
International audienceIt is estimated that half of all patients with heart failure (HF) have HF with...
Limited data exist describing the differences in the medical treatment of patients with heart failur...
Aims: The objectives of the present study were to describe epidemiology and outcomes in ambulatory h...
Over the past 20 years, there has been a surge of clinical investigations and useful trials on heart...
Significant progress in our understanding of risk factors and interventions in heart failure, a lead...
Heart failure with preserved ejection fraction (HFpEF) has recently emerged as a major cause of card...
Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the cases of...
In the current era of cardiovascular disease, the diagnosis of heart failure with preserved ejection...
Aims: A substantial proportion of patients with heart failure have preserved left ventricular ejecti...
International audienceHeart failure with preserved ejection fraction (HFPEF) is increasingly recogni...
International audienceIt is estimated that half of all patients with heart failure (HF) have HF with...
Aims A substantial proportion of patients with heart failure have preserved left ventricular ejectio...
International audienceIt is estimated that half of all patients with heart failure (HF) have HF with...
BACKGROUND: We assessed the prevalence of preserved left ventricular ejection fraction in patients w...
International audienceIt is estimated that half of all patients with heart failure (HF) have HF with...
International audienceIt is estimated that half of all patients with heart failure (HF) have HF with...
Limited data exist describing the differences in the medical treatment of patients with heart failur...
Aims: The objectives of the present study were to describe epidemiology and outcomes in ambulatory h...
Over the past 20 years, there has been a surge of clinical investigations and useful trials on heart...
Significant progress in our understanding of risk factors and interventions in heart failure, a lead...